1 류정미, "집단미술치료가 시설거주 만성 조현병 환자의 대인관계와 삶의 질에 미치는 영향" 사단법인 아시아문화학술원 6 (6): 213-232, 2015
2 박순아, "조현병 환자의 입원 스트레스 측정도구 개발" 한국간호과학회 44 (44): 339-349, 2014
3 유소연, "조현병 환자의 삶의 질 예측모형 구축" 정신간호학회 23 (23): 144-155, 2014
4 김경화, "만성 조현병 환자의 삶의 질에 관한 미술치료 사례연구" 한국미술치료학회 24 (24): 1531-1555, 2017
5 Whittemore R, "The integrative review: updated methodology" 52 (52): 546-553, 2005
6 Ministry of Health and Welfare, "The epidemiological survey of mental disorders in Korea. Ministry of Health and Welfare Statistics"
7 Jeon GS, "The effectiveness of the Nanta-program on psychiatric symptoms, interpersonal relationships, and quality of life in forensic inpatients with schizophrenia" 31 (31): 93-98, 2017
8 Kang BI, "The effect of group art therapy on emotional expression, emotional behavior, interpersonal relationship, and quality of life in inpatients with schizophrenia" 4 (4): 27-51, 2015
9 World Health Organization (WHO), "The ICD-10 online version: 2016. International Classification of Diseases [Internet]"
10 Brissos S, "Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance" 129 (129): 133-136, 2011
1 류정미, "집단미술치료가 시설거주 만성 조현병 환자의 대인관계와 삶의 질에 미치는 영향" 사단법인 아시아문화학술원 6 (6): 213-232, 2015
2 박순아, "조현병 환자의 입원 스트레스 측정도구 개발" 한국간호과학회 44 (44): 339-349, 2014
3 유소연, "조현병 환자의 삶의 질 예측모형 구축" 정신간호학회 23 (23): 144-155, 2014
4 김경화, "만성 조현병 환자의 삶의 질에 관한 미술치료 사례연구" 한국미술치료학회 24 (24): 1531-1555, 2017
5 Whittemore R, "The integrative review: updated methodology" 52 (52): 546-553, 2005
6 Ministry of Health and Welfare, "The epidemiological survey of mental disorders in Korea. Ministry of Health and Welfare Statistics"
7 Jeon GS, "The effectiveness of the Nanta-program on psychiatric symptoms, interpersonal relationships, and quality of life in forensic inpatients with schizophrenia" 31 (31): 93-98, 2017
8 Kang BI, "The effect of group art therapy on emotional expression, emotional behavior, interpersonal relationship, and quality of life in inpatients with schizophrenia" 4 (4): 27-51, 2015
9 World Health Organization (WHO), "The ICD-10 online version: 2016. International Classification of Diseases [Internet]"
10 Brissos S, "Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance" 129 (129): 133-136, 2011
11 Madhivanan S, "Symptomatic remission in schizophrenia and its relationship with functional outcome measures in Indian population" 11 (11): VC05-VC07, 2017
12 Meesters PD, "Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients" 147 (147): 275-280, 2013
13 Loh SY, "Structured walking and chronic institutionalized schizophrenia inmates: a pilot RCT study on quality of life" 8 (8): 238-248, 2016
14 Ministry of Health and Welfare, "Some amendments to the act on the promotion of mental health and support for welfare services for mentally ill patients. Bill Information [Internet]."
15 Gorna K, "Social functioning and quality of life in schizophrenia patients-relationship with symptomatic remission and duration of illness" 48 (48): 277-288, 2014
16 Goldstein JM, "Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects" 162B (162B): 698-710, 2013
17 Galuppi A, "Schizophrenia and quality of life: how important are symptoms and functioning?" 4 (4): 1-8, 2010
18 Owen MJ, "Schizophrenia" 388 (388): 86-97, 2016
19 Enhancing the QUAlity and Transparency Of health Research, "Reporting guidelines for main study types" EQ UATOR
20 Wunderink L, "Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance strategy" 70 : 913-920, 2013
21 Hsiao CY, "Quality of life of individuals with schizophrenia living in the community: relationship to socio-demographic, clinical and psychosocial characteristics" 21 (21): 2367-2376, 2012
22 Pitkanen A, "Patient education methods to support quality of life and functional ability among patients with schizophrenia: a randomized clinical trial" 21 (21): 247-256, 2012
23 Scottish Intercollegiate Guidelines Network (SIGN), "Methodology check list 2: randomized controlled trials" SIGN
24 Wang H, "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015" 388 (388): 1459-1544, 2016
25 Schlosser D, "Feasibility of PRIME: a cognitive neuroscience-informed mobile app intervention to enhance motivated behavior and improve quality of life in recent onset schizophrenia" 5 (5): e77-, 2016
26 Choi HM, "Effect of the group art therapy on stress coping strategy and quality of life in schizophrenia patients" 4 (4): 131-150, 2015
27 Wang FZ, "Combined intervention with education and progressive muscle relaxation on quality of life, functional disability, and positive symptoms in patients with acute schizophrenia" 21 (21): 159-165, 2015
28 Priebe S, "Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time" 133 (133): 17-21, 2011
29 Marshall M, "Assertive community treatment for people with severe mental disorders" 13 (13): 2011
30 Lambert M, "Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with Quetiapine immediate release (ACCESS Trial)" 71 (71): 1313-1323, 2010